Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PF-07248144 Plus Fulvestrant in Advanced Breast Cancer
NCT07062965Phase 3Recruiting
- Sponsor
- Pfizer
- Start
- Aug 2025
- Primary completion
- Jul 2027
- Modality
- Small Molecules
- Countries
- 31
01
Overview
A Phase 3 trial of prifetrastat in breast cancer, sponsored by Pfizer. Started Aug 2025; status: recruiting.
02
Drugs
prifetrastat
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT07062965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07062965.